Commercial Physical & Biological Research Industry - SEC Form 4 Insider Trading Screener
Services Sector - Engineering, Accounting, Research, Management Services - Commercial Physical & Biological Research
100 results - 
- 
- 
- 
- 
- 
- 
- - - - - - | TC | cnt | 1d | 1w | 1m | 6m |
X |
Filing Date |
Trade Date |
Ticker |
Company | Insider Name | Insider Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2019-06-17 | EXEL | Exelixis, Inc. | Lamb Peter | EVP, Scientific Strategy, CSO | S - Sale+OE | $20.59 | -217,404 | 134,302 | -62% | -$4,477,307 | |||||
| D | 2019-06-17 | INCY | Incyte Corp | Swain Paula J | EVP, HR | S - Sale+OE | $80.00 | -2,500 | 36,513 | -6% | -$200,000 | |||||
| D | 2019-06-13 | EXEL | Exelixis, Inc. | Lamb Peter | EVP, Scientific Strategy, CSO | S - Sale+OE | $20.03 | -27,596 | 134,302 | -17% | -$552,748 | |||||
2019-06-13 | BASI | Bioanalytical Systems Inc | Neff R Matthew | Dir | P - Purchase | $1.98 | +1,410 | 22,125 | +7% | +$2,792 | ||||||
| M | 2019-06-12 | BASI | Bioanalytical Systems Inc | Leasure Robert Jr. | Pres, CEO | P - Purchase | $1.97 | +5,004 | 110,619 | +5% | +$9,858 | |||||
2019-06-14 | BASI | Bioanalytical Systems Inc | Oakley Daniel Thomas | COO | P - Purchase | $1.99 | +7,500 | 28,452 | +36% | +$14,925 | ||||||
2019-06-11 | BASI | Bioanalytical Systems Inc | Blumhoff Jill | VP, Finance, CFO | P - Purchase | $1.98 | +500 | 1,811 | +38% | +$990 | ||||||
2019-06-10 | EXEL | Exelixis, Inc. | Haley Patrick J. | SVP, Commercial | S - Sale | $20.23 | -1,000 | 122,640 | -1% | -$20,230 | ||||||
2019-06-10 | BASI | Bioanalytical Systems Inc | Downing Philip A | SVP, Preclinical Srvcs. | P - Purchase | $1.96 | +5,000 | 25,765 | +24% | +$9,800 | ||||||
| M | 2019-06-06 | XON | Intrexon Corp | Kirk Randal J | CEO, 10% | P - Purchase | $5.24 | +322,179 | 50,397,399 | +1% | +$1,689,443 | |||||
| M | 2019-06-06 | XON | Intrexon Corp | Kirk Randal J | CEO, 10% | P - Purchase | $5.24 | +483,268 | 23,980,893 | +2% | +$2,534,162 | |||||
| M | 2019-06-06 | BASI | Bioanalytical Systems Inc | Leasure Robert Jr. | Pres, CEO | P - Purchase | $1.96 | +6,000 | 105,615 | +6% | +$11,750 | |||||
| M | 2019-06-03 | EXEL | Exelixis, Inc. | Scangos George A | Dir | S - Sale | $19.76 | -40,000 | 1,231,626 | -3% | -$790,250 | |||||
| M | 2019-05-31 | XON | Intrexon Corp | Kirk Randal J | CEO, 10% | P - Purchase | $4.91 | +135,548 | 47,799,190 | 0% | +$665,516 | |||||
| M | 2019-05-31 | XON | Intrexon Corp | Kirk Randal J | CEO, 10% | P - Purchase | $4.91 | +203,321 | 25,773,655 | +1% | +$998,269 | |||||
| M | 2019-05-29 | BASI | Bioanalytical Systems Inc | Davis Gregory Cole | Dir | P - Purchase | $1.98 | +15,000 | 20,000 | +300% | +$29,750 | |||||
| M | 2019-05-29 | XON | Intrexon Corp | Kirk Randal J | CEO, 10% | P - Purchase | $4.75 | +330,180 | 49,754,783 | +1% | +$1,567,799 | |||||
| M | 2019-05-29 | XON | Intrexon Corp | Kirk Randal J | CEO, 10% | P - Purchase | $4.75 | +495,271 | 23,250,021 | +2% | +$2,351,703 | |||||
2019-05-29 | CRL | Charles River Laboratories International Inc | Barbo William D | Corporate EVP, CCO | S - Sale | $125.96 | -1,253 | 19,701 | -6% | -$157,830 | ||||||
| D | 2019-05-29 | CRL | Charles River Laboratories International Inc | Barbo William D | Corporate EVP, CCO | S - Sale+OE | $125.16 | -4,905 | 20,954 | -19% | -$613,919 | |||||
| M | 2019-05-22 | XON | Intrexon Corp | Kirk Randal J | CEO, 10% | P - Purchase | $4.69 | +273,367 | 49,424,603 | +1% | +$1,280,804 | |||||
| M | 2019-05-22 | XON | Intrexon Corp | Kirk Randal J | CEO, 10% | P - Purchase | $4.69 | +410,050 | 22,754,750 | +2% | +$1,921,203 | |||||
| M | 2019-05-17 | XON | Intrexon Corp | Kirk Randal J | CEO, 10% | P - Purchase | $4.65 | +422,423 | 49,151,236 | +1% | +$1,966,075 | |||||
| M | 2019-05-17 | XON | Intrexon Corp | Kirk Randal J | CEO, 10% | P - Purchase | $4.65 | +633,631 | 22,344,700 | +3% | +$2,949,096 | |||||
| M | 2019-05-03 | BUDZ | Weed, Inc. | Breen Nicole M | Secretary, Treasurer, 10% | S - Sale | $0.82 | -15,474 | 24,014,353 | 0% | -$12,744 | |||||
| M | 2019-04-02 | BUDZ | Weed, Inc. | Breen Nicole M | Secretary, Treasurer, 10% | S - Sale | $0.96 | -58,821 | 24,029,827 | 0% | -$56,234 | |||||
2019-05-15 | CRL | Charles River Laboratories International Inc | Massaro George | Dir | S - Sale | $131.38 | -1,002 | 10,202 | -9% | -$131,643 | ||||||
| M | 2019-05-13 | XON | Intrexon Corp | Kirk Randal J | CEO, 10% | P - Purchase | $4.40 | +838,482 | 48,728,813 | +2% | +$3,688,026 | |||||
| M | 2019-05-13 | XON | Intrexon Corp | Kirk Randal J | CEO, 10% | P - Purchase | $4.40 | +1,257,727 | 21,711,069 | +6% | +$5,532,056 | |||||
| D | 2019-05-10 | CRL | Charles River Laboratories International Inc | Massaro George | Dir | S - Sale+OE | $134.64 | -3,140 | 12,204 | -20% | -$422,769 | |||||
2019-05-10 | EXEL | Exelixis, Inc. | Haley Patrick J. | SVP, Commercial | S - Sale | $19.58 | -1,000 | 123,640 | -1% | -$19,580 | ||||||
| D | 2019-05-08 | EXEL | Exelixis, Inc. | Morrissey Michael | Pres, CEO | S - Sale+OE | $20.15 | -42,000 | 301,726 | -12% | -$846,300 | |||||
2019-05-08 | EXEL | Exelixis, Inc. | Willsey Lance | Dir | S - Sale | $20.36 | -50,000 | 368,273 | -12% | -$1,018,000 | ||||||
2019-05-08 | NRC | National Research Corp | K/i/e Trust Under Agreement 10/24/18 | 10% | S - Sale | $40.00 | -185,088 | 4,755,013 | -4% | -$7,403,668 | ||||||
| M | 2019-05-06 | NRC | National Research Corp | K/i/e Trust Under Agreement 10/24/18 | 10% | S - Sale | $40.01 | -49,266 | 4,940,101 | -1% | -$1,970,979 | |||||
| D | 2019-05-03 | IQV | Iqvia Holdings Inc. | Knightly Kevin C | See Remarks | S - Sale+OE | $138.06 | -46,080 | 15,307 | -75% | -$6,361,805 | |||||
2019-05-03 | NRC | National Research Corp | K/i/e Trust Under Agreement 10/24/18 | 10% | S - Sale | $40.00 | -29,378 | 4,989,367 | -1% | -$1,175,152 | ||||||
2019-05-03 | EXEL | Exelixis, Inc. | Senner Christopher J. | EVP, CFO | S - Sale | $20.70 | -36,261 | 115,085 | -24% | -$750,603 | ||||||
| M | 2019-05-01 | EXEL | Exelixis, Inc. | Scangos George A | Dir | S - Sale | $19.84 | -40,000 | 1,256,626 | -3% | -$793,750 | |||||
2019-05-01 | NRC | National Research Corp | K/i/e Trust Under Agreement 10/24/18 | 10% | S - Sale | $40.01 | -1,479 | 5,018,745 | 0% | -$59,169 | ||||||
| D | 2019-04-24 | EXEL | Exelixis, Inc. | Morrissey Michael | Pres, CEO | S - Sale+OE | $20.75 | -40,000 | 301,695 | -12% | -$830,000 | |||||
2019-04-24 | NRC | National Research Corp | K/i/e Trust Under Agreement 10/24/18 | 10% | S - Sale | $40.00 | -1,532 | 5,020,224 | 0% | -$61,280 | ||||||
2019-04-23 | NRC | National Research Corp | K/i/e Trust Under Agreement 10/24/18 | 10% | S - Sale | $40.01 | -2,702 | 5,021,756 | 0% | -$108,109 | ||||||
2019-04-16 | NRC | National Research Corp | K/i/e Trust Under Agreement 10/24/18 | 10% | S - Sale | $40.01 | -7,950 | 5,024,458 | 0% | -$318,048 | ||||||
2019-04-10 | EXEL | Exelixis, Inc. | Haley Patrick J. | SVP, Commercial | S - Sale | $24.04 | -1,000 | 122,967 | -1% | -$24,040 | ||||||
| D | 2019-04-10 | EXEL | Exelixis, Inc. | Morrissey Michael | Pres, CEO | S - Sale+OE | $24.06 | -40,000 | 301,647 | -12% | -$962,400 | |||||
| M | 2019-03-19 | BUDZ | Weed, Inc. | Breen Nicole M | Secretary, Treasurer, 10% | S - Sale | $1.03 | -62,349 | 24,088,648 | 0% | -$64,037 | |||||
2019-04-12 | NRC | National Research Corp | K/i/e Trust Under Agreement 10/24/18 | 10% | S - Sale | $40.00 | -3,539 | 5,032,408 | 0% | -$141,560 | ||||||
2019-04-11 | NRC | National Research Corp | K/i/e Trust Under Agreement 10/24/18 | 10% | S - Sale | $40.00 | -1,106 | 5,035,947 | 0% | -$44,240 | ||||||
| D | 2019-04-03 | EXAS | Exact Sciences Corp | Stenhouse Mark | Pres, Cologuard | S - Sale+OE | $92.54 | -11,192 | 14,471 | -44% | -$1,035,696 | |||||
| D | 2019-04-03 | EXEL | Exelixis, Inc. | Schwab Gisela | Pres, Prod Dev, Med Aff, CMO | S - Sale+OE | $25.00 | -63,109 | 331,251 | -16% | -$1,577,725 | |||||
| D | 2019-04-01 | EXEL | Exelixis, Inc. | Wyszomierski Jack L | Dir | S - Sale+OE | $23.97 | -7,822 | 120,209 | -6% | -$187,493 | |||||
| M | 2019-04-01 | EXEL | Exelixis, Inc. | Scangos George A | Dir | S - Sale | $24.13 | -45,000 | 1,296,626 | -3% | -$1,085,950 | |||||
| D | 2019-04-01 | EXEL | Exelixis, Inc. | Hessekiel Jeffrey | EVP, GC | S - Sale+OE | $24.03 | -20,000 | 234,819 | -8% | -$480,600 | |||||
| D | 2019-04-01 | EXEL | Exelixis, Inc. | Garber Alan M | Dir | S - Sale+OE | $23.98 | -30,000 | 61,329 | -33% | -$719,550 | |||||
| M | 2019-04-01 | SYN | Synthetic Biologics, Inc. | Kirk Randal J | 10% | S - Sale | $0.66 | -150,565 | 227,674 | -40% | -$98,837 | |||||
2019-04-01 | IQV | Iqvia Holdings Inc. | Evanisko Michael J | Dir | S - Sale | $144.95 | -1,193 | 3,772 | -24% | -$172,925 | ||||||
| D | 2019-04-01 | INCY | Incyte Corp | Swain Paula J | EVP, HR | S - Sale+OE | $87.01 | -10,000 | 73,026 | -12% | -$870,100 | |||||
2019-03-29 | MEDP | Medpace Holdings, Inc. | Ewald Stephen P | GC, Corp. Secy. | S - Sale | $57.95 | -7,946 | 0 | -100% | -$460,471 | ||||||
| M | 2019-03-29 | MEDP | Medpace Holdings, Inc. | Geiger Jesse J | CFO, COO, Lab Operations | S - Sale | $59.42 | -37,037 | 0 | -100% | -$2,200,620 | |||||
2019-03-29 | VBIO | Vitality Biopharma, Inc. | Loconti Joseph E. | 10% | P - Purchase | $0.46 | +4,447,651 | 13,153,063 | +51% | +$2,045,919 | ||||||
| D | 2019-03-27 | EXEL | Exelixis, Inc. | Morrissey Michael | Pres, CEO | S - Sale+OE | $23.39 | -40,000 | 301,598 | -12% | -$935,600 | |||||
| D | 2019-03-29 | EXEL | Exelixis, Inc. | Poste George | Dir | S - Sale+OE | $23.89 | -3,860 | 102,475 | -4% | -$92,215 | |||||
| D | 2019-03-25 | EXEL | Exelixis, Inc. | Schwab Gisela | Pres, Prod Dev, Med Aff, CMO | S - Sale+OE | $23.14 | -100,000 | 331,251 | -23% | -$2,314,000 | |||||
| D | 2019-03-26 | EXEL | Exelixis, Inc. | Haley Patrick J. | SVP, Commercial | S - Sale+OE | $23.47 | -2,700 | 123,967 | -2% | -$63,369 | |||||
| D | 2019-03-25 | IQV | Iqvia Holdings Inc. | Bousbib Ari | See Remarks | S - Sale+OE | $140.96 | -96,000 | 1,273,439 | -7% | -$13,532,160 | |||||
2019-03-21 | NRC | National Research Corp | K/i/e Trust Under Agreement 10/24/18 | 10% | S - Sale | $40.00 | -1,300 | 5,037,053 | 0% | -$52,001 | ||||||
| M | 2019-03-19 | NRC | National Research Corp | K/i/e Trust Under Agreement 10/24/18 | 10% | S - Sale | $40.01 | -4,807 | 5,038,353 | 0% | -$192,321 | |||||
2019-03-15 | BASI | Bioanalytical Systems Inc | Oakley Daniel Thomas | COO | P - Purchase | $1.90 | +1 | 20,952 | 0% | +$2 | ||||||
| M | 2019-03-11 | BUDZ | Weed, Inc. | Breen Nicole M | Secretary, Treasurer, 10% | S - Sale | $1.16 | -51,500 | 24,150,997 | 0% | -$59,820 | |||||
2019-03-14 | EXEL | Exelixis, Inc. | Scangos George A | Dir | S - Sale | $25.00 | -5,000 | 1,341,626 | 0% | -$125,000 | ||||||
| D | 2019-03-14 | EXEL | Exelixis, Inc. | Haley Patrick J. | SVP, Commercial | S - Sale+OE | $25.00 | -2,000 | 123,782 | -2% | -$50,000 | |||||
| D | 2019-03-13 | EXEL | Exelixis, Inc. | Morrissey Michael | Pres, CEO | S - Sale+OE | $24.64 | -40,000 | 301,550 | -12% | -$985,486 | |||||
| M | 2019-03-01 | BUDZ | Weed, Inc. | Breen Nicole M | Secretary, Treasurer, 10% | S - Sale | $1.10 | -17,500 | 24,202,497 | 0% | -$19,240 | |||||
| M | 2019-03-13 | NRC | National Research Corp | K/i/e Trust Under Agreement 10/24/18 | 10% | S - Sale | $40.00 | -6,663 | 5,043,160 | 0% | -$266,539 | |||||
2019-03-14 | BASI | Bioanalytical Systems Inc | Sagartz John E | Dir, 10% | P - Purchase | $1.94 | +1,400 | 621,525 | 0% | +$2,716 | ||||||
2019-03-12 | BASI | Bioanalytical Systems Inc | Leasure Robert Jr. | Pres, CEO | P - Purchase | $1.94 | +6,000 | 99,615 | +6% | +$11,640 | ||||||
2019-03-11 | EXEL | Exelixis, Inc. | Haley Patrick J. | SVP, Commercial | S - Sale | $23.13 | -959 | 123,782 | -1% | -$22,182 | ||||||
| M | 2019-03-11 | NRC | National Research Corp | K/i/e Trust Under Agreement 10/24/18 | 10% | S - Sale | $40.00 | -10,518 | 5,049,823 | 0% | -$420,720 | |||||
| D | 2019-03-11 | EXAS | Exact Sciences Corp | Coward D Scott | Chief Administrative Officer | S - Sale+OE | $87.21 | -2,774 | 106,978 | -3% | -$241,926 | |||||
| D | 2019-03-11 | EXAS | Exact Sciences Corp | Conroy Kevin T | Pres, CEO | S - Sale+OE | $87.21 | -11,227 | 1,029,628 | -1% | -$979,129 | |||||
2019-03-08 | IQV | Iqvia Holdings Inc. | Connaughton John | Dir | S - Sale | $140.80 | -868,684 | 2,015,534 | -30% | -$122,310,707 | ||||||
2019-03-08 | IQV | Iqvia Holdings Inc. | Tpg Group Holdings (Sbs) Advisors, Inc. | Dir | S - Sale | $140.80 | -4,044,480 | 8,531,251 | -32% | -$569,462,784 | ||||||
2019-03-08 | CRL | Charles River Laboratories International Inc | Laplume Joseph W | EVP, Corp Strategy, Develop | S - Sale | $138.23 | -1,666 | 13,413 | -11% | -$230,295 | ||||||
2019-03-08 | CRL | Charles River Laboratories International Inc | Laplume Joseph W | EVP, Corp Strategy, Develop | S - Sale | $138.01 | -5,770 | 15,079 | -28% | -$796,337 | ||||||
| D | 2019-03-08 | CRL | Charles River Laboratories International Inc | Laplume Joseph W | EVP, Corp Strategy, Develop | S - Sale+OE | $137.61 | -5,522 | 20,849 | -21% | -$759,892 | |||||
2019-03-08 | BASI | Bioanalytical Systems Inc | Leasure Robert Jr. | Pres, CEO | P - Purchase | $1.77 | +4,000 | 93,615 | +4% | +$7,080 | ||||||
2019-03-08 | BASI | Bioanalytical Systems Inc | Neff R Matthew | Dir | P - Purchase | $1.75 | +5,715 | 20,715 | +38% | +$10,001 | ||||||
2019-03-06 | BASI | Bioanalytical Systems Inc | Oakley Daniel Thomas | COO | P - Purchase | $1.75 | +10,000 | 20,951 | +91% | +$17,500 | ||||||
| M | 2019-03-04 | XON | Intrexon Corp | Reed Thomas D. | Chief Science Officer | S - Sale | $4.19 | -227,800 | 203,265 | -53% | -$954,408 | |||||
2019-03-01 | IQV | Iqvia Holdings Inc. | Evanisko Michael J | Dir | S - Sale | $142.71 | -1,193 | 4,965 | -19% | -$170,253 | ||||||
| D | 2019-03-01 | INCY | Incyte Corp | Swain Paula J | EVP, HR | S - Sale+OE | $86.68 | -10,000 | 36,513 | -21% | -$866,800 | |||||
2019-03-01 | BASI | Bioanalytical Systems Inc | Oakley Daniel Thomas | COO | P - Purchase | $1.54 | +125 | 10,951 | +1% | +$193 | ||||||
| D | 2019-02-27 | EXEL | Exelixis, Inc. | Morrissey Michael | Pres, CEO | S - Sale+OE | $22.69 | -40,000 | 301,499 | -12% | -$907,600 | |||||
2019-03-01 | EXEL | Exelixis, Inc. | Scangos George A | Dir | S - Sale | $22.66 | -40,000 | 1,346,626 | -3% | -$906,400 | ||||||
| M | 2019-02-22 | BUDZ | Weed, Inc. | Breen Nicole M | Secretary, Treasurer, 10% | S - Sale | $0.05 | -520,688 | 24,219,997 | -2% | -$25,109 | |||||
2019-02-28 | EXAS | Exact Sciences Corp | Zanotti Katherine S | Dir | S - Sale | $92.81 | -25,000 | 77,102 | -24% | -$2,320,231 | ||||||
2019-02-28 | EXAS | Exact Sciences Corp | Wyzga Michael S | Dir | S - Sale | $96.00 | -500 | 8,612 | -5% | -$48,000 | ||||||
2019-02-28 | EXAS | Exact Sciences Corp | Johnson Scott C. | SVP - Research, Development | S - Sale | $93.20 | -1,166 | 7,845 | -13% | -$108,676 | ||||||
2019-02-28 | EXAS | Exact Sciences Corp | Elliott Jeffrey Thomas | CFO | S - Sale | $93.20 | -2,447 | 41,604 | -6% | -$228,070 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |